NasdaqGM - Delayed Quote USD
PureTech Health plc (PRTC)
At close: October 18 at 4:00 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.4 | -0.5 |
| Low Estimate | 0 | 0 | -0.4 | -0.5 |
| High Estimate | 0 | 0 | -0.4 | -0.5 |
| Year Ago EPS | -- | -- | -6.4 | -0.4 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | -- | -- | 18.4M | 20.6M |
| Low Estimate | -- | -- | 5.3M | 12.7M |
| High Estimate | -- | -- | 31.5M | 28.5M |
| Year Ago Sales | -- | -- | 3.33M | 18.4M |
| Sales Growth (year/est) | -- | -- | 452.60% | 12.00% |
Earnings History
| CURRENCY IN USD | |
|---|---|
| EPS Est. | -- |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.4 | -0.5 |
| 7 Days Ago | 0 | 0 | -0.4 | -0.5 |
| 30 Days Ago | 0 | 0 | -0.49 | -0.54 |
| 60 Days Ago | 0 | 0 | -0.5 | -0.5 |
| 90 Days Ago | 0 | 0 | -0.5 | -0.5 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PRTC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.70% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | 93.80% | -- | -- | 2.50% |
| Next Year | -25.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight | 8/25/2022 |
| Maintains | SVB Leerink: Outperform | 8/9/2022 |
| Maintains | SVB Leerink: Outperform | 6/15/2022 |
| Maintains | SVB Leerink: Outperform | 1/7/2022 |
| Maintains | SVB Leerink: Outperform | 8/25/2021 |
| Initiated | SVB Leerink: Outperform | 1/15/2021 |
Related Tickers
SOLTF Nxera Pharma Co., Ltd.
7.13
0.00%
GLSHQ Gelesis Holdings, Inc.
0.0021
0.00%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.1500
+8.46%
FNCH Finch Therapeutics Group, Inc.
12.05
+2.56%
ERAS Erasca, Inc.
2.9100
+3.93%
SCPH scPharmaceuticals Inc.
4.5300
+3.19%
PHAR Pharming Group N.V.
9.16
+5.18%
CRGX CARGO Therapeutics, Inc.
22.22
+2.40%
IRON Disc Medicine, Inc.
50.56
+0.14%
SLRN Acelyrin, Inc.
6.20
-4.32%